We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Emv Capital Plc (EMVC) ORD GBP0.05

Sell:43.00p Buy:45.00p 0 Change: 1.10p (2.47%)
Market closed |  Prices as at close on 26 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:43.00p
Buy:45.00p
Change: 1.10p (2.47%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 26 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:43.00p
Buy:45.00p
Change: 1.10p (2.47%)
Market closed |  Prices as at close on 26 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

EMV Capital plc, formerly NetScientific plc, is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It employs a capital-light investment approach, making use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital Partners Limited. It secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a structure that can support a large portfolio. It develops customized, proactive investment strategies for its subsidiaries and portfolio companies. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its subsidiaries include Glycotest, Inc., and ProAxsis Limited, among others.

Contact details

Address:
20 St Andrew Street
LONDON
EC4A 3AG
United Kingdom
Telephone:
+44 (020) 30112234
Website:
https://emvcapital.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 30 September 2024 30/09/24

General stock information

EPIC:
EMVC
ISIN:
GB00BN4R5Q82
Market cap:
£10.39 million
Shares in issue:
23.95 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Ilian Iliev
    Chief Executive Officer, Executive Director
  • Stephen Crowe
    Chief Financial Officer, Company Secretary
  • Edward Hooper
    General Counsel, Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.